{"PubmedArticle": [{"MedlineCitation": {"SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "OtherAbstract": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "PMID": "11301868", "DateCompleted": {"Year": "2001", "Month": "05", "Day": "10"}, "DateRevised": {"Year": "2013", "Month": "11", "Day": "21"}, "Article": {"ArticleDate": [], "Language": ["eng"], "ELocationID": [], "Journal": {"ISSN": "0032-0943", "JournalIssue": {"Volume": "67", "Issue": "2", "PubDate": {"Year": "2001", "Month": "Mar"}}, "Title": "Planta medica", "ISOAbbreviation": "Planta Med"}, "ArticleTitle": "Lignans as anti-tumor-promoter from the seeds of Hernandia ovigera.", "Pagination": {"StartPage": "166", "EndPage": "168", "MedlinePgn": "166-8"}, "Abstract": {"AbstractText": ["Seven lignans (2-8) isolated from the seeds of Hernandia ovigera L. (Hernandiaceae) were tested for their inhibitory effects on Epstein-Barr virus early antigen activation induced by 12-O-tetradecanoylphorbol 13-acetate in Raji cells. Using a primary screening test, all the lignans showed inhibitory activity with IC50 470-590 mol ratio/32 pmol TPA. The data demonstrated that these lignans might be valuable anti-tumor-promoters."]}, "AuthorList": [{"AffiliationInfo": [], "Identifier": [], "LastName": "Ito", "ForeName": "C", "Initials": "C"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Itoigawa", "ForeName": "M", "Initials": "M"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Ogata", "ForeName": "M", "Initials": "M"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Mou", "ForeName": "X Y", "Initials": "XY"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Tokuda", "ForeName": "H", "Initials": "H"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Nishino", "ForeName": "H", "Initials": "H"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Furukawa", "ForeName": "H", "Initials": "H"}], "PublicationTypeList": ["Letter", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "Germany", "MedlineTA": "Planta Med", "NlmUniqueID": "0066751", "ISSNLinking": "0032-0943"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Anticarcinogenic Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Antigens, Viral"}, {"RegistryNumber": "0", "NameOfSubstance": "Epstein-Barr virus early antigen"}, {"RegistryNumber": "0", "NameOfSubstance": "Lignans"}, {"RegistryNumber": "NI40JAQ945", "NameOfSubstance": "Tetradecanoylphorbol Acetate"}], "MeshHeadingList": [{"QualifierName": ["isolation & purification", "therapeutic use"], "DescriptorName": "Anticarcinogenic Agents"}, {"QualifierName": ["drug effects"], "DescriptorName": "Antigens, Viral"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["isolation & purification", "therapeutic use"], "DescriptorName": "Lignans"}, {"QualifierName": [], "DescriptorName": "Molecular Structure"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Precursor Cell Lymphoblastic Leukemia-Lymphoma"}, {"QualifierName": ["chemistry"], "DescriptorName": "Seeds"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Tetradecanoylphorbol Acetate"}, {"QualifierName": ["drug effects"], "DescriptorName": "Tumor Cells, Cultured"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2001", "Month": "4", "Day": "17", "Hour": "10", "Minute": "0"}, {"Year": "2001", "Month": "5", "Day": "22", "Hour": "10", "Minute": "1"}, {"Year": "2001", "Month": "4", "Day": "17", "Hour": "10", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["11301868", "10.1055/s-2001-11501"]}}], "PubmedBookArticle": []}